Notice for International Patients & Caregivers
English summary does not mean the trial enrolls international patients. Multiple myeloma interventional clinical trials in China typically require valid Chinese resident identity/national healthcare insurance and strict adherence to China's Human Genetic Resources Administration regulations.
Hubei Multiple Myeloma Active Trials & Centers
As of 2026-10-21, there are 37 active clinical trials for multiple myeloma hosted across 8 tertiary medical centers in Hubei (including Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Yichang Central People's Hospital, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, etc.).
Participating Medical Centers (8)
Active Studies in Hubei (37)
Population synthesized by CMDNShowing 0 published English records of 37 registry trials.
All 37 local registry studies currently have Chinese-only filings. Verified English summaries will be published upon regulatory audit.